Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.86B | 11.42B | 10.18B | 8.96B | 6.73B | 7.60B |
Gross Profit | 2.72B | 2.64B | 2.40B | 1.86B | 1.96B | 2.10B |
EBITDA | 2.47B | 2.92B | 2.61B | 2.20B | 1.52B | 1.30B |
Net Income | 819.20M | 945.72M | 733.21M | 499.59M | 587.76M | -65.00M |
Balance Sheet | ||||||
Total Assets | 42.17B | 43.53B | 41.85B | 42.90B | 39.13B | 27.35B |
Cash, Cash Equivalents and Short-Term Investments | 3.77B | 3.64B | 2.99B | 2.59B | 1.82B | 99.99M |
Total Debt | 13.07B | 14.00B | 15.07B | 16.75B | 14.80B | 4.53B |
Total Liabilities | 22.23B | 23.97B | 23.67B | 25.41B | 22.52B | 11.77B |
Stockholders Equity | 17.57B | 17.20B | 15.97B | 15.33B | 14.51B | 13.57B |
Cash Flow | ||||||
Free Cash Flow | 2.10B | 1.94B | 1.93B | -1.06B | -10.07B | -2.94B |
Operating Cash Flow | 2.41B | 2.27B | 2.30B | 2.04B | 2.14B | 738.01M |
Investing Cash Flow | -455.07M | -165.85M | -147.64M | -2.98B | -12.14B | -3.44B |
Financing Cash Flow | -1.49B | -1.37B | -1.90B | 1.74B | 10.07B | 2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥6.43B | 7.63 | 3.19% | -9.85% | -8.43% | ||
77 Outperform | ¥63.79B | 14.17 | 2.43% | 18.84% | 113.24% | ||
74 Outperform | ¥94.07B | 11.61 | 332.12% | 5.77% | 11.61% | ||
69 Neutral | ¥30.31B | 9.80 | 3.62% | 8.60% | 93.71% | ||
66 Neutral | ¥12.10B | 13.42 | 5.12% | 1.05% | 5.06% | ||
56 Neutral | HK$23.37B | 3.96 | -1.56% | 6.69% | 0.06% | -64.88% | |
51 Neutral | ¥5.94B | ― | ― | 28.89% | -2448.94% |